Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers With HIV

Next Previous
Trial Profile

Testing Novel Pharmacogenetic and Adherence Optimization Treatments to Improve the Effectiveness of Smoking Cessation Treatments for Smokers With HIV

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 10 Dec 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nicotine (Primary) ; Varenicline (Primary)
  • Indications Smoking withdrawal
  • Focus Therapeutic Use
  • Acronyms HTO

Most Recent Events

  • 06 Dec 2024 Planned End Date changed from 30 Jun 2025 to 31 Aug 2025.
  • 06 Dec 2024 Planned primary completion date changed from 31 Dec 2024 to 31 Aug 2025.
  • 16 Nov 2022 Planned number of patients changed from 488 to 340.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top